7 Analysts Assess Alkermes: What You Need To Know
Throughout the last three months, 7 analysts have evaluated Alkermes (NASDAQ:ALKS), offering a diverse set of opinions from ...
ALKS Stock Earnings: Alkermes Misses EPS, Misses Revenue for Q1 2024
ALKS stock results show that Alkermes missed analyst estimates for earnings per share and missed on revenue for the first ...
Alkermes Buy Rating Affirmed on Strong Commercial Performance and Promising Drug Pipeline
Goldman Sachs analyst Chris Shibutani maintained a Buy rating on Alkermes (ALKS – Research Report) today and set a price target of ...
Yahoo Finance6d
Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
DUBLIN, May 2, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility in Athlone, Ireland to Novo Nordisk.
Alkermes: Q1 Earnings Snapshot
DUBLIN — DUBLIN — Alkermes PLC (ALKS) on Wednesday reported first-quarter net income of $36.8 million, after reporting a loss in the same period a year earlier. The Dublin-based company said it had ...
Yahoo Finance6d
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
Alkermes plc ALKS reported adjusted earnings from continuing operations of 44 cents per share for first-quarter 2024, which ...
SFGate7d
Alkermes: Q1 Earnings Snapshot
DUBLIN (AP) — DUBLIN (AP) — Alkermes PLC (ALKS) on Wednesday reported first-quarter net income of $36.8 million, after reporting a loss in the same period a year earlier. The Dublin-based ...